Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
Cancer., Feb;112(3 Suppl):673-8 (2008)
Review of gene-expression profiling and its clinical use in breast cancer.
Crit. Rev. Oncol. Hematol., Jan;69(1):1-11 (2009)
Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer.
Expert Opin Drug Saf., Sep;10(5):819-26 (2011)
Role of fulvestrant in sequential hormonal therapy for advanced, hormone receptor-positive breast cancer in postmenopausal women.
Clin. Breast Cancer., Apr;6 Suppl 1:S15-22 (2005)
Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
Clin. Cancer Res., Feb;12(3 Pt 2):997s-1000s (2006)
A 62-year-old woman with a new diagnosis of breast cancer.
JAMA., Mar;295(12):1434-42 (2006)
The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer.
N. Engl. J. Med., May;334(21):1356-61 (1996)
Treatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer.
Int. J. Radiat. Oncol. Biol. Phys., Aug;45(1):69-72 (1999)
Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
Clin. Cancer Res., Jan;9(1 Pt 2):443S-6S (2003)
Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lung.
Cancer., Feb;67(4):892-5 (1991)
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.
J. Clin. Oncol., Apr;26(12):1993-9 (2008)
Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons.
Clin. Breast Cancer., Jun;7(2):158-61 (2006)
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.
Invest New Drugs., Aug;25(4):369-75 (2007)
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer.
Breast Cancer Res. Treat., Feb;131(3):1061-6 (2012)
Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.
J. Clin. Oncol., Nov;23(33):8340-7 (2005)
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.
J. Clin. Oncol., Mar;23(9):1934-40 (2005)
Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome.
J. Clin. Oncol., Sep;9(9):1662-7 (1991)
Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer.
Int. J. Radiat. Oncol. Biol. Phys., Apr;25(5):765-70 (1993)
Co-Author, "Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer"
Clinical Cancer Research
A 62-year-old woman with a new diagnosis of breast cancer
JAMA: Journal of the American Medical Association